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Abstract
Influenza A virus infection is an ongoing clinical problem and thus, there is an urgent need to understand the mechanisms
that regulate the lung inflammation in order to unravel novel generic pharmacological strategies. Evidence indicates that
the Nox2-containing NADPH oxidase enzyme promotes influenza A virus-induced lung oxidative stress, inflammation and
dysfunction via ROS generation. In addition, lung epithelial and endothelial cells express the Nox1 isoform of NADPH
oxidase, placing this enzyme at key sites to regulate influenza A virus-induced lung inflammation. The aim of this study was
to investigate whether Nox1 oxidase regulates the inflammatory response and the oxidative stress to influenza infection
in vivo in mice. Male WT and Nox1-deficient (Nox12/y) mice were infected with the moderately pathogenic HkX-31 (H3N2,
16104 PFU) influenza A virus for analysis of bodyweight, airways inflammation, oxidative stress, viral titre, lung
histopathology, and cytokine/chemokine expression at 3 and 7 days post infection. HkX-31 virus infection of Nox12/y mice
resulted in significantly greater: loss of bodyweight (Day 3); BALF neutrophilia, peri-bronchial, peri-vascular and alveolar
inflammation; Nox2-dependent inflammatory cell ROS production and peri-bronchial, epithelial and endothelial oxidative
stress. The expression of pro-inflammatory cytokines including CCL2, CCL3, CXCL2, IL-1b, IL-6, GM-CSF and TNF-a was higher
in Nox12/y lungs compared to WT mice at Day 3, however, the expression of CCL2, CCL3, CXCL2, IFN-c and the anti-
inflammatory cytokine IL-10 were lower in lungs of Nox12/y mice vs. WT mice at Day 7. Lung viral titre, and airways
infiltration of active CD8+ and CD4+ T lymphocytes, and of Tregs were similar between WT and Nox12/y mice. In conclusion,
Nox1 oxidase suppresses influenza A virus induced lung inflammation and oxidative stress in mice particularly at the early
phases of the infection. Nox1 and Nox2 oxidases appear to have opposing roles in the regulation of inflammation caused by
influenza A viruses.
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Introduction
Influenza A virus infections represent important infectious
diseases that continue to inflict significant global morbidity and
mortality [1]. The effects of influenza infection vary from strain to
strain, ranging from transient debilitating respiratory illness to
more severe respiratory complications that are sometimes fatal.
Seasonal and pandemic influenza infections over the last century
have claimed over 50 million lives and impose a huge socio-
economic burden [2].
Accumulated animal and human studies provide compelling
evidence for a new paradigm whereby excessive production of
reactive oxygen species (ROS), such as superoxide anion, and its
derivatives hydrogen peroxide and peroxynitrite, are crucial
mediators of the acute lung injury to influenza A virus infection
[3–5]. However, although the evidence supporting a pathogenic
role for ROS in lung injury to influenza A virus is strong, little
attention has been directed towards identifying the key enzymes
that generate ROS. Knowledge of the culprit enzymes could give
rise to novel pharmacological strategies for manipulating oxidative
stress and the associated lung injury following influenza A virus
infection.
Recently the Nox2 isoform of the NADPH oxidase family of
superoxide-generating enzymes was identified as a major player in
the lung pathology caused by influenza A virus infection. Mice
genetically deficient in the Nox2 subunit or in a key regulatory
subunit of Nox2 activity, p47phox, demonstrated substantially
lower: 1) superoxide production by bronchoalveolar lavage fluid
(BALF) inflammatory cells and lung oxidative stress; 2) lung
oedema and injury; 3) alveolar lung epithelial apoptosis; and 4)
peribronchial inflammation compared to WT mice [4,6,7].
Moreover, a lack of Nox2 oxidase activity resulted in improved
lung function [8]. Despite the reduction in airways and BALF
inflammation, viral clearance was not compromised but was
significantly improved in the Nox2 deficient mice [6,8]. Finally,
the protective effects of Nox2 deficiency against influenza A virus
infection appeared to occur irrespective of the infecting strain,
highlighting the exciting therapeutic potential of targeting Nox2
oxidase [6,7].
Notwithstanding the important role of Nox2, a number of
additional sources of superoxide, such as the Nox1 isoform of the
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NADPH oxidase family, are expressed in lungs and may therefore
influence the inflammatory response to influenza A virus infection.
It is noteworthy that Nox1 mRNA has been identified in lung
epithelial and endothelial cells, potentially placing the enzyme at
key sites to regulate cytokine production and lung inflammation
following an influenza viral infection [9]. However, it is so far
unknown if Nox1 influences lung inflammation in response to
influenza A virus infection. Thus, in the present study we
performed an extensive phenotypic analysis of the clinical features
of influenza A virus infection in the novel Nox1-deficient mouse.
The present study shows that Nox1 oxidase critically inhibits the
early burst in lung pro-inflammatory cytokine expression, in-
flammation and oxidative stress caused by influenza A virus
infection and therefore, as opposed to the Nox2 oxidase, Nox1 is
a protective mechanism against such infections.
Results
Expression of Nox1
A Nox1 specific antibody revealed strong immunofluorescence
in the endothelium of blood vessels and in alveolar epithelial cells
of lung sections taken from WT mice that was not evident in
equivalent lung sections from Nox12/y mice (Figure 1). The lack of
fluorescence in the Nox12/y lung sections verifies the specificity of
the antibody for Nox1.
Pro-inflammatory Cytokine and Chemokine Expression in
Lungs from Nox12/y Mice
We assessed mRNA levels of several pro-inflammatory and anti-
inflammatory (IL-10) cytokines and chemokines in the lungs of
naı¨ve and HkX-31 infected WT and Nox12/y mice at early (i.e.
Day 3) and later (i.e. Day 7) stages of the infection phase with
quantitative real time PCR. Naı¨ve WT and Nox12/y mice had
similar levels of CCL3, CXCL2, IL-b, IL-6, TNF-a, IFN-c, GM-
CSF and IL-10 although CCL2 levels were,1.7 fold higher in the
Nox12/y lungs (Figure S1). At 3 days post HkX-31 infection in
WT mice the levels of all the cytokines and chemokines examined
were significantly elevated (Figure 2). However, the levels of all the
cytokines and chemokines examined, with the exception of IFN-c
and IL-10 were elevated in Nox12/y mice following influenza
infection and to a greater extent ($2–3 fold) than in WT mice
(Figure 2). By contrast, at 7 days post infection, the levels of CCL2,
CCL3, CXCL2, IFN-c and the anti-inflammatory cytokine IL-10
were significantly lower in influenza A virus-infected Nox12/y lung
compared to WT control, whereas IL-b, IL-6, TNF-a, and GM-
CSF were similar between the two strains of mice (Figure 2).
Histological Investigation of Lung Inflammation
At 3 days post infection, there was evidence of peri-bronchial
inflammation, inflammatory cell exudates in some airways and
signs of peri-vascular inflammation in the lungs of WT mice
(Figure 3). However, the degree of peri-bronchial and peri-
vascular inflammation was substantially greater in the lungs of
Nox12/y mice with evidence of alveolitis (Figure 3 and Figure S2).
At Day 7 post infection, WT mice demonstrated a greater degree
of airways inflammation compared to Day 3 characterized by
bronchial thickening, peri-bronchial and peri-vascular inflamma-
tion and a mild degree of alveolitis (Figure 4). The overall peri-
bronchial, and in particular, the peri-vascular inflammation
observed in the Nox12/y lung sections was substantially greater
(Figure 4). Also, there was evidence of significant and more
widespread alveolitis (Figure 4).
Airway Cellularity in Response to Hk-X31
The extent of cellular infiltration in the BALF of WT and
Nox12/y mice infected with HkX-31 virus was investigated at 3
Figure 1. Localization of Nox1 to lung endothelium and alveolar epithelial cells in WT and Nox12/y mice. Representative
photomicrographs (n = 5) show cellular localization of Nox1 in lungs from WT (A–B) and Nox12/y (C) mice infected with HkX-31 (H3N2) influenza A
virus on Day 3. Note, magnification of X200 and X400. Nox1 immunoreactivity is shown in green. BV = blood vessel.
doi:10.1371/journal.pone.0060792.g001
Nox1 Oxidase and Influenza A Virus Infection
PLOS ONE | www.plosone.org 2 April 2013 | Volume 8 | Issue 4 | e60792
and 7 days post infection. Naı¨ve Nox12/y mice had similar total
cell numbers in the BALF to naı¨ve WT mice (Figure 5). However,
3 days after infection, the cellular infiltrate in WT mice increased
by ,10 fold from basal levels, which was similar in Nox12/y mice
(Figure 5). By Day 7 post infection, the total number of cells in
Nox12/y mice was similar again when compared to WT mice
(Figure 5). Analyses of the infiltrating and resident populations
revealed that at 3 days post HkX-31 infection, BALF from
Nox12/y mice contained a strong trend for higher numbers of
neutrophils than WT mice (Figure 5). When these data were
expressed as a percentage of the total number of cells in the BALF,
the proportion of neutrophils from Nox12/y mice was significantly
higher (P,0.05) than WT mice (Figure 5). Analysis of macro-
phages indicated no significant difference in the total numbers of
the cells between the two strains of mice, however, the percentage
of macrophages was modestly but significantly lower in Nox12/y
mice than WT mice (Figure 5). By day 7, there were no significant
differences in total numbers or percentages of neutrophils or
macrophages in the BALF between the WT and Nox12/y mice
(Figure 5).
Effect of Nox1 Deletion on Nox2-dependent Superoxide
Production in BALF Inflammatory Cells
We examined basal and phorbol dibutyrate (PDB)-stimulated
superoxide production (oxidative burst solely due to Nox2 oxidase
[6]) by inflammatory cells in BALF of HkX-31-infected WT and
Nox12/y mice. BALF inflammatory cells from WT mice infected
with HkX-31 produced superoxide under basal conditions and in
the presence of PDB, superoxide production increased by ,20
fold (Figure 6). BALF inflammatory cells from Nox12/y produced
similar levels of basal superoxide to WT mice, however, the PDB-
stimulated signal was significantly higher (,30 fold higher than
basal) than that observed in WT mice (Figure 6). The increase in
PDB-dependent superoxide generation was also significantly
greater in the Nox12/y BALF cells compared to WT cells at
Day 7 (Figure 6).
We assessed whether there was a compensatory alteration in
Nox2 expression in the lungs of Nox12/y mice that could explain
the increase in PDB-dependent superoxide production in the
BALF inflammatory cells of Nox12/y mice. Using Western
blotting, there were no differences observed in the expression of
Nox2 in naı¨ve Nox12/y mice lungs and in Nox12/y lungs at D3
and D7 post infection compared to WT mice (Figure S3).
Figure 2. Lung cytokine and chemokine levels. Effect of HkX-31 (H3N2) influenza A virus infection on CCL2, CCL3, CXCL2, IL-1b, IL-6, TNF-a, IFN-
c, GMCSF and IL-10 mRNA expression in whole lung obtained from WT and Nox12/y mice 3 days and 7 days post infection. Gene expression levels are
shown as fold change relative to naı¨ve (uninfected) WT mice shown in supplementary Figure E1 after normalisation to 18S rRNA (housekeeping
gene). Data are shown as mean 6 SEM of 4 individual mice. *P,0.05 vs WT (HkX-31) (Student’s unpaired t test).
doi:10.1371/journal.pone.0060792.g002
Nox1 Oxidase and Influenza A Virus Infection
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Effect of Nox1 Deletion on Lung Peroxynitrite Production
and Localization
Lung sections taken at Day 3 from WT mice infected with
HkX-31 displayed immunofluorescence for 3-nitrotyrosine in the
inflammatory cells that infiltrated the airways and in peri-
bronchial regions (Figure 7). 3-NT staining was also visible in
the alveolar space, associated with inflammatory cells (Figure 7).
Of note, very little peri-vascular 3-NT staining was observed in the
blood vessels surrounding the airways. By contrast, the overall 3-
NT immunofluorescence intensity observed in lung sections
obtained from Nox12/y mice infected with HkX-31 was markedly
greater (Figure 7) particularly in the peri-bronchial and peri-
vascular regions, as well as the epithelium. Strikingly, nearly all of
the airways observed had significant fluorescence in the epitheli-
um. Also evident was a significant degree of 3-NT fluorescence in
the endothelium of blood vessels that were in close proximity to
major airways (Figure 7).
At Day 7 post infection, 3-NT fluorescence was still evident in
the lung sections of WT mice with a similar pattern of fluorescence
as seen at Day 3 including peri-bronchial and epithelial
fluorescence (Figure S4). The intensity of 3-NT staining in lungs
from Nox12/y mice was again markedly greater with nearly all
epithelial cell layers of the airways observed to possess significant
3-NT fluorescence.
We also performed 3-NT immunofluorescence in lung
sections taken from HkX-31-infected Nox22/y mice. There
Figure 3. Histological investigation of lung inflammation in HkX-31 virus-infected WT and Nox-12/y mice 3 days post infection. (A–
D) Hematoxylin and eosin stained paraffin sections of lungs from WT and Nox12/y mice obtained at Day 3. WT mice lungs had obvious peribronchial
and perivascular inflammation. However, Nox12/y mice displayed considerably more peribronchial and perivascular inflammation (shown in bold
white arrow) and mild degrees of alveolitis. Note, magnification of6100 and6200. (E) Corresponding histopathological scores for peribronchial
inflammation and alveolitis. Lung sections were scored blind for alveolitis and peribronchiol inflammation from 0 to 5 as described in Materials and
Methods. Data shown represent scores from individual mice (as indicated by circles) and median values (as indicated by bar) obtained from one of
two independent readers. For each reader, peribronchial inflammation and alveolitis were significantly higher in HKx31-infected Nox-12/y mice
compared with HkX-31-infected WT mice (*P,0.05, Mann-Whitney Wilcoxon test).
doi:10.1371/journal.pone.0060792.g003
Nox1 Oxidase and Influenza A Virus Infection
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was a clear reduction in the 3-NT fluorescence intensity in the
airways epithelium, peri-bronchial regions and endothelium of
blood vessels in sections from Nox22/y vs WT mice (Figure S5
and [6]).
Effect of Nox1 Deletion on Bodyweight Loss and Viral
Titers
Following HkX-31 infection, Nox12/y mice generally lost
a greater percentage of their bodyweight than WT mice,
however this was only significantly different at Day 3 (Figure 8).
Also, we observed no significant differences in viral titers
between the WT and Nox12/y mice (Figure 8) demonstrating
Figure 4. Histological investigation of lung inflammation in HkX-31 virus-infected WT and Nox-12/y mice 7 days post infection.
Hematoxylin and eosin stained paraffin sections of lungs from WT and Nox12/y mice obtained at Day 7. WT mice lungs had some peribronchial and
perivascular inflammation (A–C). However, Nox12/y mice displayed markedly greater degrees of peribronchial and perivascular inflammation with
higher levels of alveolitis (D–F). Note, magnification of6100 and6400. (G) Corresponding histopathological scores for peribronchial inflammation
and alveolitis. Lung sections were scored blind for alveolitis and peribronchial inflammation from 0 to 5 as described in Materials and Methods. Data
shown represent scores from individual mice (as indicated by circles) and median values (as indicated by bar) obtained from one of two independent
readers. For each reader, peribronchial inflammation and alveolitis were significantly higher in HkX-31-infected Nox-12/y mice compared with HKx31-
infected WT mice (*P,0.05, Mann-Whitney Wilcoxon test).
doi:10.1371/journal.pone.0060792.g004
Nox1 Oxidase and Influenza A Virus Infection
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that Nox1 does not influence either viral replication or
mechanisms of viral clearance.
Effect of Nox1 Deletion on the Magnitude and Function
of T Lymphocyte Subsets
We investigated the effect of Nox12/y deficiency on the number
and functionality of CD8+ and CD4+ T cells and of T regulatory
cells at Day 7 post infection. HkX-31 infection elicited T cell
infiltration into the airways and there were no differences in the
number of CD8+, CD4+ and Tregs in the BALF infiltrate of WT
and Nox12/y mice (Figure 9). In addition, there were no
differences in the numbers of CD8+ T cells expressing either
CD44 or CD69 (activation markers), or in the numbers of CD4+ T
cells expressing CD69, between lungs from WT and Nox12/y
mice (Figure 9).
Figure 5. Effect of HkX-31 influenza A virus infection on BALF cellularity in WT and Nox12/y mice. Mice were treated with 16104 PFU of
HkX-31 (H3N2) strain of influenza A virus and the number of (A) total cells, (B) neutrophils and (C) macrophages, and the percentage of (D)
neutrophils and (E) macrophages counted in cytospin preparations of BALF 3 and 7 days post infection. In (A–C) Naı¨ve (horizontal hash), HkX-31 (Day
3; open histogram) and HkX-31 (Day 7; filled histogram). Data are shown as mean 6 SEM for 7–12 mice per group. *P,0.05 vs WT (ANOVA and
Dunnett’s post hoc test).
doi:10.1371/journal.pone.0060792.g005
Figure 6. Superoxide production from BALF cells. BALF cells were obtained from HkX-31 influenza A virus-infected WT and Nox12/y mice 3
days post infection and (A) basal and (B) phorbol dibutyrate (1 mM)-stimulated superoxide production was measured by L-O12 (5 mM) enhanced
chemiluminescence. Note, in (B) the PDB-dependent superoxide production was represented as a fold increase above basal levels, which is a measure
of the oxidative burst capacity of the cells. Data are shown as mean6 SEM for 7–12 mice per treatment group. *P,0.05 vs WT (ANOVA and Dunnett’s
post hoc test).
doi:10.1371/journal.pone.0060792.g006
Nox1 Oxidase and Influenza A Virus Infection
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Discussion
The role of the Nox1 oxidase in the inflammation caused by
influenza infection has not previously been determined. The major
finding of the present study is that the Nox1 oxidase expressed in
lung endothelial and epithelial cells plays a somewhat unexpected
role in suppressing the early burst in pro-inflammatory cytokine
expression and in the oxidative stress and inflammation in the
lungs following influenza virus infection. This protective effect of
Nox1 is surprising given that ROS have previously been
implicated in promoting the lung injury and dysfunction to
influenza virus infection. Indeed, excessive ROS production by the
Nox2 oxidase was shown to contribute to the early lung injury and
dysfunction caused by influenza [4,6–8]. Hence, the current study
highlights the complex role ROS play in modulating influenza
disease progression.
In the present study, we demonstrate localization of Nox1
protein in lung epithelium, in particular the alveolar epithelium, as
Figure 7. Effect of HkX-31 influenza A virus infection on lung oxidative stress (i.e. peroxynitrite levels). Representative sections of lung
tissue obtained from WT (A & C) and Nox12/y mice (B & D) infected with HkX-31 were incubated with mouse monoclonal anti-3-nitrotyrosine
antibody (1:50) followed by biotinylated anti-mouse IgG reagent. WT mouse lung sections displayed immunofluorescence for 3-NT in the
peribronchial regions, in inflammatory cells that infiltrated the airways and in the alveolar tissue and in some regions of the epithelial and endothelial
cell layer. In contrast, Nox12/y mice displayed markedly greater degrees of immunofluorescence for 3-NT and distribution. In particular there was
substantially greater degrees of immunofluorescence in the peri-bronchial and peri-vascular regions (mainly due to inflammatory cells and alveolar
epithelial cells), endothelial cells and in epithelial cells of most airways examined compared to the WT mice.
doi:10.1371/journal.pone.0060792.g007
Figure 8. Effect of HkX-31 influenza A virus infection on viral titer and body weight in WT and Nox12/y mice. Mice were treated with
16104 PFU of HkX-31 (H3N2) strain of influenza A virus and (A) body weight recorded for up to 7 days post infection and (B) viral titer determined 3
and 7 days post infection. Data are shown as mean6SEM for 23 mice per group. *P,0.05 vs WT (ANOVA and Dunnett’s post hoc test).
doi:10.1371/journal.pone.0060792.g008
Nox1 Oxidase and Influenza A Virus Infection
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well as in vascular endothelium. These observations are consistent
with the recent work of Carnesecchi et al 2009 who showed
localization of Nox1 mRNA to the lung alveolar epithelial and
endothelial cells [9]. This pattern of expression of Nox1 in the lung
places the enzyme at primary sites to orchestrate the inflammation
caused by an influenza infection. However, surprisingly the
absence of Nox1 resulted in a marked increase in a number of
pro-inflammatory cytokines that are key in regulating the in-
flammation to influenza viruses at an early stage of the infection
i.e. Day 3. The suite of cytokines and chemokines assessed here,
namely, TNF-a, IL-6, CCL2, CCL3, CXCL2 and IL-1b, are
known to promote the inflammation caused by influenza at early
stages of the infection phase, i.e. during the cytokine storm, and
have been shown to underpin the pathology and morbidity
[10,11]. Indeed, early dysregulation of innate cellular and cytokine
responses predict disease severity and death arising from highly
pathogenic inuenza virus infection [12–14] and are associated with
symptoms in humans [15]. We also assessed cytokine and
chemokine production at 7 days post infection. Surprisingly, some
of the same pro-inflammatory cytokines and chemokines i.e.
CCL2, CCL3, CXCl2 and GM-CSF that were significantly
elevated in the lungs of Nox12/y mice at D3 were, by contrast,
slightly but significantly lower at D7. However, at the same Day 7
time point the reduced expression of the anti-inflammatory
cytokine IL-10 perhaps counteracts the reduction in pro-in-
flammatory cytokines. Overall it appears that at Day 7, there may
be a balance reached between pro- and anti-inflammatory
cytokines that help resolve the infection. Indeed at Day 7, there
is a significant decrease in viral titer compared to Day 3 indicating
resolution of infection. Overall, whether ROS stimulate or
suppress cytokine and chemokine production is highly complex
and we suggest will be dependent on a number of factors including
the level of ROS generated, the type of ROS generated (i.e.
superoxide, hydrogen peroxide etc.), the subcellular compartmen-
talization of ROS generation and suite of transcription factors
expressed within the vicinity of ROS that ultimately regulate the
expression of the cytokines and chemokines. These factors
certainly warrant further investigation.
The present study also demonstrated that Nox12/y mice
infected with HkX-31 influenza A virus displayed a modest but
increased weight loss at Day 3 compared to WT mice, reflecting
the exacerbated pro-inflammatory cytokine/chemokine expression
profile in these mice at that time point. In addition, the lungs of
Nox12/y mice displayed a significantly greater degree of in-
flammation, as assessed by H & E staining. This was characterized
by an enhanced presence of inflammatory cells, particularly within
the peri-bronchial and peri-vascular regions that persisted into D7
after the influenza insult. Interestingly the pattern of inflammation
mirrored the localization pattern of Nox1, i.e. peri-vascular
inflammation coinciding with Nox1 expression in endothelium,
and the alveolitis coinciding with Nox1 expression in the alveolar
epithelium. We also assessed BALF inflammation after a pulmo-
nary challenge with Hk-X31 influenza A virus. At Day 3, lungs of
infected Nox12/y mice contained slightly higher numbers of
neutrophils in the BALF compared to WT lungs, but had fewer
macrophages. The enhanced neutrophilia is possibly a conse-
quence of an increase in expression of the neutrophil chemotactic
chemokine CXCL2 and the cytokine IL-1b. The biological
significance of these relatively modest effects on BALF cellularity
is unknown, but even the small increase in neutrophilia could
conceivably be a major contributor to oxidative stress given the
high capacity of neutrophils to generate ROS via Nox2 oxidase.
Macrophages and neutrophils that either reside in the lung or
have been recruited to the lung play crucial roles in regulating the
host response against influenza A virus infections. However,
whether macrophages and neutrophils have an overall protective
effect or detrimental effect is controversial. For instance depletion
of macrophages in pigs resulted in a significant increase in
mortality and histopathological features compared to controls
suggesting that macrophages are indispensable for controlling
H1N1 influenza A virus ( [16]). Similarly antibody depletion of
neutrophils in mice resulted in an increase in disease severity
following influenza infection of mice, however, the beneficial
effects of neutrophils appears to be dependent on the virulence of
the particular strain examined ( [17]). By contrast, several studies
suggest that an excessive host innate response characterized by
a large infiltration of macrophages and neutrophils is an un-
derlying cause of the lung pathology caused by influenza A virus.
Activated macrophages and neutrophils produce large amounts of
superoxide, and in excessive amounts superoxide is capable of
inducing significant injury to surrounding tissue via its ability to
give rise to a number of ROS and reactive nitrogen species with
a high oxidising capacity, such as OONO2 and OH. [18]. These
molecules have detrimental biological effects such as nitration and
oxidation of macromolecules, including proteins and DNA,
leading to apoptosis via the caspase 3 pathway [18]. We have
previously shown that the primary source of superoxide in lungs
from influenza-infected mice is Nox2 oxidase – as BALF cells
isolated from Nox22/y mice produced almost no superoxide either
basally or following stimulation with PDB [6]. Moreover the lungs
of Nox22/y mice produced substantially less peroxynitrite than
those from WT mice, indicating that Nox2 is the major source of
peroxynitrite induced by influenza A virus infection [6]. In the
present study, deletion of Nox1 resulted in a substantial increase
Figure 9. T cell enumeration from BALF obtained from HkX-31
influenza A virus infected WT and Nox12/y mice 7 days post
infection. (A and B) Group data of flow cytometric plots for CD8+, CD4+
and CD4+CD25+FoxP3+ T cells from BALF from HkX-31 virus-infected WT
and Nox12/y mice. Data are shown as mean6 SEM of 5 individual mice.
(C and D) Group data as mean 6 SEM of 5 individual mice of the
number of active i.e. CD69+ and CD44+ CD8+ and CD4+ T cell
populations in the BALF.
doi:10.1371/journal.pone.0060792.g009
Nox1 Oxidase and Influenza A Virus Infection
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in: 1) the Nox2-dependent, oxidative burst capacity of BALF
inflammatory cells, which are predominantly macrophages and
neutrophils; and 2) oxidative stress (i.e. 3-nitrotyrosine staining) in
a number of locations in the lungs. It is unlikely that the increase in
Nox2 dependent oxidative burst and lung oxidative stress is due to
a compensatory increase in Nox2 expression in the Nox12/y mice,
as we have shown in the present study and as shown by
Carnesecchi et al [9]. A possible reason for the enhanced oxidative
burst by inflammatory cells is greater priming of Nox2 oxidase by
pro-inflammatory mediators such as TNF-a, IL-1b and GM-CSF,
all of which were elevated in naı¨ve Nox12/y mice lungs compared
to WT resulting in an increase in activation of Nox2 oxidase.
Elevated degrees of oxidative stress were observed in the lung
epithelium, vascular endothelium, and peri-bronchial and peri-
vascular regions. This pattern of oxidative stress is most likely due
to the enhanced presence of inflammatory cells observed in these
regions. Another potential cause of the increased oxidative stress
seen in Nox12/y lungs is reduced expression of the transcription
factor Nrf2, which plays an important role in transcriptional
upregulation of several antioxidant genes since previous studies
have shown that Nrf2 expression is under the influence of Nox1
oxidase [19]. This could lead to a reduction in the antioxidant
profile in epithelium resulting in the enhanced proinflammatory
cytokine release. As mentioned above the increased cytokine levels
in the lung milieu could activate/prime Nox2 in phagocytes
resulting in the enhanced oxidative stress. These potential
mechanisms of crosstalk between Nox1 and Nox2 oxidases are
speculative at this stage but certainly warrant further investigation.
We also addressed whether Nox1 deletion influences the
adaptive immune response that is ultimately responsible for
clearing influenza viruses from the lungs. To achieve this we
evaluated the amounts of several subsets of T lymphocytes
including cytotoxic CD8+ T lymphocytes, effector CD4+ T cells
and regulatory T lymphocytes i.e. CD25+CD4+FoxP3+. In
addition we assessed the activation state of the CD8+ and CD4+
T cells by measuring expression of the cell surface activation
markers CD69 and CD44. Our findings indicate that Nox1 does
not influence T cell-mediated immunity, as there were no
differences in the numbers of these relevant T lymphocyte subsets
between WT and Nox12/y mice before or after influenza
infection. As further evidence of an intact adaptive immune
response, viral titers were similar at both D3 and D7 between WT
and Nox12/y mice lungs. Overall, these findings indicate that
Nox1 is a strong suppressor of airways and lung inflammation and
oxidative stress that occurs during the early stages of the infection
phase, particularly when the innate immune system is maximally
active. By contrast, Nox1 appears to have a minor role in
regulating the adaptive arm of the immune response that clear the
virus.
Our findings that Nox1 and Nox2 oxidases have profoundly
different effects in regulating the inflammation and oxidative stress
caused by influenza A virus infection warrants further investiga-
tion. Indeed at face value, it is intriguing that these enzymes
possess such contrasting effects, given that they generate the same
enzymatic product i.e. superoxide [20,21]. A possible reason for
this opposition is related to differences in cell type and oxidase
properties. Specifically, Nox2 is highly expressed in phagocytic
cells and generates high levels of extracellular ROS to kill invading
pathogens with a side-effect of this action being the production of
peroxynitrite leading to oxidative damage to surrounding host
tissues. By contrast, as shown in the present study Nox1 is
expressed in airway epithelial cells and as opposed to Nox2 is
responsible for low-level intracellular ROS production for cell
signalling purposes [22] [23].
In conclusion, the present study evaluated the role of Nox1
oxidase in the lung inflammation and oxidative stress caused by
influenza A virus infection. It demonstrates for the first time
a protective effect of Nox1 following infection by an external
pathogen, in this case influenza viruses. It remains to be
determined whether Nox1 has similar protective effects against
the lung inflammation and injury evoked by other viruses such as
rhinovirus and respiratory syncytial virus (RSV), or by acute or
chronic bacterial and fungal infection. Our study also highlights
intriguing differences between Nox1 and Nox2 oxidases in
regulation of lung inflammation and injury following influenza A
virus infection. Surprisingly, the overall effect of Nox1 appears to
be anti-inflammatory and to protect the host from oxidative stress.
By contrast, Nox2 promotes inflammation, and is responsible for
the oxidative stress-dependent lung injury and dysfunction. Our
findings might explain why ROS scavengers generally fail to
provide significant protection against influenza because they are
likely to remove both the detrimental toxic effects of Nox2-derived
ROS and the protective properties of Nox1-derived ROS.
Therefore, selective targeting of Nox2 oxidase is likely to be
a better therapeutic strategy than utilizing non-selective ROS
scavengers. When used in combination with anti-viral drugs,
selective Nox2 inhibitors might be an effective approach to target
the host immune response for influenza A virus therapy.
Materials and Methods
Mice
Male wild type (WT, C57BL/6) and Nox1 deficient (Nox12/y)
mice (C57BL/6 background) aged between 7 and 12 weeks and
weighing ,25 g were bred at the Department of Pharmacology at
Monash University. The animals were housed under specific
pathogen-free conditions at 20uC on a 12 h day/night cycle in
sterile micro-isolators and fed a standard sterile diet of Purina
mouse chow with water allowed ad libitum.
Animal Ethics Statement
The experiments described in this manuscript were approved by
the Animal Experimentation Ethics Committee of The University
of Melbourne and conducted in compliance with the guidelines of
the National Health and Medical Research Council (NHMRC) of
Australia on animal experimentation.
Infection of WT and Nox12/y Mice
Male naı¨ve WT and Nox12/y mice were anaesthetized by
methoxyflurane inhalation and infected with 16104 plaque
forming units (PFU) of HkX-31 strain (H3N2) i.n. in 35 ml of
PBS. At days 3 (peak of viral titres) or 7 (resolution of infection)
following influenza infection, mice were euthanized by an i.p.
injection of sodium pentobarbitone (360 mg/kg).
Quantitative Real-Time PCR
Whole lungs were perfused free of blood via right ventricular
perfusion with 10 ml of pre-warmed saline, rapidly excised en
bloc, blotted and snap frozen in liquid nitrogen. Total RNA was
extracted from whole lung tissue (15 mg) using the RNeasy mini
kits (Qiagen). RNA was transcribed into cDNA with high capacity
RNA to cDNA kit (Applied Biosystems) for use in real time PCR
reactions with Applied Biosystems pre-developed assay reagents
and 18S rRNA internal control as previously described [24–27].
Histology
Histology was performed as previously described
[6,24,25,28,29] and sections stained with haematoxylin and eosin
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(H&E) for general histopathology. Airway inflammation of H&E-
stained lung sections was evaluated on a subjective scale of 0, 1, 2,
3, 4, or 5 (corresponding to no inflammation and very mild, mild,
moderate, marked, and severe inflammation, respectively) on
randomized, blinded sections by two independent readers as
previously published [28,29]. Tissues were graded for peribron-
chial inflammation and alveolitis in multiple random fields per
section [28,29].
Airways Inflammation and Differential Cell Counting
Lungs from each mouse were lavaged in situ with a 400 ml
volume, followed by three 300 ml volumes of PBS. The total
number of viable cells in the BALF was determined, cytospins
prepared using 50 to 200 ml BALF, and cells differentiated by
standard morphologic criteria as previously described [6]. The
remaining BALF was spun at 800 g for 5 min to pellet cells for
flow cytometry and superoxide detection.
Superoxide Detection with L-O12 Enhanced
Chemiluminescence
BALF inflammatory cells were exposed to the chemiluminescent
probe, L-O12 (100 mM; Wako laboratories, Japan) in the absence
(for basal measurements) or presence of the PKC and NADPH
oxidase activator, phorbol dibutyrate (1 mM; Sigma) and dis-
pensed into 96 well white opti-plates for luminescence reading
with the TopCount (Perkin Elmer Packard). Photon emission was
recorded from each well every 2 min and averaged over 45 min.
Individual data points for each group were derived from the
average of 3 replicates. We have previously shown incubation of
cells with superoxide dismutase (SOD; 600 U/ml) to inactivate
superoxide almost abolishes the chemiluminescence signal verify-
ing that the L-O12 chemiluminescence signal was due to
superoxide [6].
Western Blotting
Western blotting was performed as we have previously shown
[30–34]. Lungs were snap-frozen in liquid nitrogen and pulverised
using a mortar and pestle. Following pulverisation, 0.4–0.5 ml of
Laemmli buffer (5% glycerin, 2.5% mercaptoethanol, 1.5%
sodium dodecyl sulphate (SDS), 50 mmol/L Tris-HCl, pH 8,
and 0.05 mg/mL bromphenol blue) was added to each sample.
Tissue homogenates were then sonicated (cycle 0.5, amplitude
80%) for 10 s using a Hielscher ultrasonic processor (UPSOH,
Germany) and then heated on a heating block at 37uC for 10 min.
The supernatant was removed by centrifugation at 15,0006g for
5 min at 4uC, and samples were stored at –20uC until analysis.
Protein concentrations of tissue samples were determined using the
RC DCTM protein kit according to the manufacturer’s specifica-
tions. Matched protein amounts of varying concentration
(depending on the tissue type) were loaded onto 10% poly-
acrylamide gels. Samples were then resolved by SDS–poly-
acrylamide gel electrophoresis and transferred onto a polyvinyli-
dene fluoride (PVDF) membrane. Following transfer, membranes
were blocked in 5% non-fat dry milk (Bio-Rad blotting-grade
blocker) for 1 h at room temperature and then incubated
overnight at 4uC with a Nox2 antibody, (monoclonal; BD
Transduction Laboratories; dilution 1:1000). Membranes were
then washed three times at 10 min intervals with Tris-buffered
saline-tween (TBS-T) and then incubated for 1 h at room
temperature with anti-mouse secondary antibody (Jackson Im-
munoResearch; dilution 1:10000) conjugated to horseradish
peroxidase. Membranes were again washed in TBS-T
(3610 min) and immunoreactive bands were visualized following
1–30 min exposure to enhanced chemiluminescence (ECL) re-
agent (Blok-CH, Millipore) or (GE Healthcare ECL-advance) on
X-ray film (Super RX; Kodak). Immunoreactive bands were
quantified using ChemiDoc XRS Imager and Quantity One
software (Bio-Rad). Following visualization, membranes were
stripped in 0.5 M NaOH for 20 min and incubated with a primary
antibody against b-actin (monoclonal; Sigma, St Louis, MO, USA;
dilution 1:5000) to assess protein loading and for normalization of
immunoreactive bands.
Immunohistochemistry for 3-NT
Lung sections from WT and Nox12/y mice infected with Hk-
X31 were deparaffinised, fixed in acetone for 15 min and then
washed in 0.01 M phosphate buffered saline (PBS, pH 7.4; 3610
min) before staining for 3-NT, as previously published [6]. Tissue
mounted sections were incubated in either mouse monoclonal
anti-3-nitrotyrosine (1:50, AbCAM), mouse monoclonal anti-Nox2
(1:250, AbCAM), mouse monoclonal anti-Nox1 (1:250; AbCAM)
overnight in a humid box. The following day, tissues were washed
in 0.01 M PBS (3610 min) to remove any excess antibody, and
incubated in a biotinylated anti-mouse IgG reagent for 10 min for
3-nitrotyrosine studies or a goat anti-rabbit Alexa fluor 488
(Invitrogen; 1:500) secondary antibody for Nox1. Lung sections
were then washed in 0.01 M PBS (3610 min) and Fluorescein
Avidin DCS (Vector Laboratories) was applied for 5 min. Sections
were washed in 0.01 M PBS (3610 min) and cover slipped. Slides
were viewed and photographed on an Olympus fluorescence
microscope. Several independent researchers were blinded
throughout the experiment and all the appropriate primary and
secondary controls were performed.
Viral Titres
Lungs from influenza virus-infected mice were removed,
weighed and homogenised in 2 ml of RPMI medium 1640. The
plaque assay on Madin-Darby Canine Kidney (MDCK) cell
monolayers as previously published [35] was used to quantify viral
titers.
Flow Cytometry
BALF leukocytes isolated from WT and Nox12/y mice were
centrifuged (8006g), washed twice with PBS and containing 0.5%
BSA (staining buffer), and 16106 cells re-suspended in staining
buffer. The cells were then stained for 25 minutes at 4uC with
fluorescently labeled antibodies for surface markers including
CD4, CD8, CD69, CD44 and CD25. All surface antibodies were
obtained from BD Biosciences. Following surface staining, cells
were washed twice with staining buffer and then fixed and
permeabilized using a FoxP3/T regulatory cell kit (eBioscience)
according to manufacturer’s instructions. Intracellular staining for
the T regulatory cell transcription factor FoxP3 was performed on
fixed/permeabilized cells through incubation with a fluorescently
labeled anti-FoxP3 antibody (eBioscience) at room temperature for
15 minutes. Cells were then washed twice with staining buffer and
re-suspended in staining buffer containing 1% paraformaldehyde
until analyzed using LSR-II flow cytometer with DIVA software
(BD Bioscience). Data was analyzed with Flowjo software (Version
9.3.3, Treestar).
Materials
Antibodies for staining were used in different multi-color
combinations and were either from BD Biosciences (V450 anti-
CD45 (30-F11); V500 anti-CD3 (145-2C11); APC-Cy7 anti-CD44
(IM7); PE anti-CD69 (H1.2F3); PE-Cy7 anti-CD8a (53-6.7); APC
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anti-CD25 (7D4)) or eBioscience (FITC anti-CD4 (RM4-5), PE
anti-FoxP3 (FJK-16s)). An eBioscience Mouse Regulatory T Cell
staining kit (88-8111) was used to stain T regulatory cells from
BALF.
Statistical Analyses
Data are presented as mean 6 standard error of the mean
(SEM); n represents the number of mice. Differences in BALF cell
types and whole lung mRNA expression were determined by
analysis of variance (ANOVA) followed by Dunnett post hoc test for
multiple comparisons, where appropriate. In some cases, Student’s
unpaired t-test was used to determine if there were significant
differences between means of pairs. All statistical analyses were
performed using GraphPad Prism for Windows (Version 5.0). In
all cases, probability levels less than 0.05 (*P,0.05) were taken to
indicate statistical significance.
Supporting Information
Figure S1 Lung cytokine and chemokine levels. Effect of
HkX-31 (H3N2) influenza A virus infection on CCL2, CCL3,
CXCL2, IL-1b, IL-6, TNF-a, IFN-c, GMCSF and IL-10 mRNA
expression in whole lung obtained from naı¨ve WT and Nox12/y
mice. Gene expression levels are shown as fold change relative to
naı¨ve (uninfected) WT mice after normalisation to 18S rRNA
(housekeeping gene). Data are shown as mean 6 SEM of 4
individual mice. *P,0.05 vs WT (Students’ unpaired t test).
(TIF)
Figure S2 Lung histology showing representative peri-
vascular inflammation in response to HkX-31 influenza
A virus infection in mice. Hematoxylin and eosin stained
paraffin sections of lungs from WT and Nox12/y mice obtained at
Day 3. Note, magnification of X400.
(TIF)
Figure S3 Effect of Nox1 deletion on Nox2 expression in
naı¨ve and HkX-31 influenza A virus infected mice.
Western blot image showing protein expression of Nox2 protein
in lung tissue taken from naı¨ve wild type and Nox12/y mice (lanes
1 and 2), WT and Nox12/y lungs at D3 (lanes 3 and 4) and at Day
7 (lanes 5 and 6). This is a representative blot from 4 separate
experiments.
(TIF)
Figure S4 Effect of HkX-31 influenza A virus infection
on lung oxidative stress (i.e. peroxynitrite generation).
Representative sections of lung tissue obtained from WT and
Nox12/y mice infected with HkX-31 were incubated with mouse
monoclonal anti-3-nitrotyrosine antibody (1:50) followed by
biotinylated anti-mouse IgG reagent.
(TIF)
Figure S5 Effect of Nox2 deletion on HkX-31 influenza A
virus infection induced lung oxidative stress (i.e.
peroxynitrite generation). Representative sections of lung
tissue obtained from Nox22/y mice infected with HkX-31 were
incubated with mouse monoclonal anti-3-nitrotyrosine antibody
(1:50) followed by biotinylated anti-mouse IgG reagent.
(TIF)
Acknowledgments
The authors wish to acknowledge Professor Karl-Heinz Krause from the
University of Geneva for generating and providing the Nox1-deficient
mouse and Dr John Stambas from The School of Medicine, Deakin
University for supplying the HkX-31 virus.
Author Contributions
Conceived and designed the experiments: SS RV. Performed the
experiments: SS HJS BRSB AV RV. Analyzed the data: SS HJS BRSB
AV SB CGS GRD RV. Contributed reagents/materials/analysis tools: SS
SB GRD CGS RV. Wrote the paper: SS HJS BRSB AV SB CGS GRD
RV.
References
1. Doherty PC, Turner SJ, Webby RG, Thomas PG (2006) Influenza and the
challenge for immunology. Nat Immunol 7: 449–455.
2. Newall AT, Scuffham PA, Hodgkinson B (2007) Economic Report into the cost
of influenza to the Australian Health System; Report to the Influenza Specialist
Group. 1–19.
3. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, et al. (1996) Pathogenesis of
influenza virus-induced pneumonia: involvement of both nitric oxide and
oxygen radicals. Proc Natl Acad Sci U S A 93: 2448–2453.
4. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, et al. (2008)
Identification of oxidative stress and Toll-like receptor 4 signaling as a key
pathway of acute lung injury. Cell 133: 235–249.
5. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, et al. (1989) Oxygen
radicals in influenza-induced pathogenesis and treatment with pyran polymer-
conjugated SOD. Science 244: 974–976.
6. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, et al.
(2011) Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced
lung inflammation. PLoS Pathog 7: e1001271.
7. Vlahos R, Stambas J, Selemidis S (2012) Suppressing production of reactive
oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci 33:
3–8.
8. Snelgrove RJ, Edwards L, Rae AJ, Hussell T (2006) An absence of reactive
oxygen species improves the resolution of lung influenza infection. Eur J Immunol
36: 1364–1373.
9. Carnesecchi S, Deffert C, Pagano A, Garrido-Urbani S, Metrailler-Ruchonnet I,
et al. (2009) NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute
lung injury in mice. Am J Respir Crit Care Med 180: 972–981.
10. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of self-
preservation: immunopathology in influenza virus infection. Immunol Cell Biol
85: 85–92.
11. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, et al. (2011)
Endothelial cells are central orchestrators of cytokine amplification during
influenza virus infection. Cell 146: 980–991.
12. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, et al.
(2009) Th1 and Th17 hypercytokinemia as early host response signature in
severe pandemic influenza. Crit Care 13: R201.
13. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. (2004) Enhanced
virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic
virus. Nature 431: 703–707.
14. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate
immune response in lethal infection of macaques with the 1918 influenza virus.
Nature 445: 319–323.
15. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG (2001) Symptom
pathogenesis during acute influenza: interleukin-6 and other cytokine responses.
J Med Virol 64: 262–268.
16. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, et al. (2008) Alveolar
macrophages are indispensable for controlling influenza viruses in lungs of pigs.
J Virol 82: 4265–4274.
17. Tate MD, Ioannidis LJ, Croker B, Brown LE, Brooks AG, et al. (2011) The role
of neutrophils during mild and severe influenza virus infections of mice. PLoS
One 6: e17618.
18. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry,
pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:
662–680.
19. Malec V, Gottschald OR, Li S, Rose F, Seeger W, et al. (2011) HIF-1 alpha
signaling is augmented during intermittent hypoxia by induction of the Nrf2
pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med
48: 1626–1635.
20. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating
oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat
Rev Drug Discov 10: 453–471.
21. Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR (2008)
NADPH oxidases in the vasculature: molecular features, roles in disease and
pharmacological inhibition. Pharmacol Ther 120: 254–291.
Nox1 Oxidase and Influenza A Virus Infection
PLOS ONE | www.plosone.org 11 April 2013 | Volume 8 | Issue 4 | e60792
22. Oakley FD, Abbott D, Li Q, Engelhardt JF (2009) Signaling components of
redox active endosomes: the redoxosomes. Antioxid Redox Signal 11: 1313–
1333.
23. Miller FJ, Jr., Chu X, Stanic B, Tian X, Sharma RV, et al. (2010) A differential
role for endocytosis in receptor-mediated activation of Nox1. Antioxid Redox
Signal 12: 583–593.
24. Vlahos R, Bozinovski S, Chan SP, Ivanov S, Linden A, et al. (2010) Neutralizing
granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-
induced lung inflammation. Am J Respir Crit Care Med 182: 34–40.
25. Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, et al. (2006) Differential
protease, innate immunity, and NF-kappaB induction profiles during lung
inflammation induced by subchronic cigarette smoke exposure in mice.
Am J Physiol Lung Cell Mol Physiol 290: L931–945.
26. Chen H, Hansen MJ, Jones JE, Vlahos R, Anderson GP, et al. (2007)
Detrimental metabolic effects of combining long-term cigarette smoke exposure
and high-fat diet in mice. Am J Physiol Endocrinol Metab 293: E1564–1571.
27. Prause O, Bossios A, Silverpil E, Ivanov S, Bozinovski S, et al. (2009) IL-17-
producing T lymphocytes in lung tissue and in the bronchoalveolar space after
exposure to endotoxin from Escherichia coli in vivo–effects of anti-inflammatory
pharmacotherapy. Pulm Pharmacol Ther 22: 199–207.
28. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, et al. (2009)
Neutrophils ameliorate lung injury and the development of severe disease during
influenza infection. J Immunol 183: 7441–7450.
29. Yatmaz S, Seow HJ, Gualano RC, Wong ZX, Stambas J, et al. (2012)
Glutathione Peroxidase-1 (GPx-1) Reduces Influenza A Virus-Induced Lung
Inflammation. Am J Respir Cell Mol Biol.
30. Harrison CB, Selemidis S, Guida E, King PT, Sobey CG, et al. (2012)
NOX2beta: A novel splice variant of NOX2 that regulates NADPH oxidase
activity in macrophages. PLoS One 7: e48326.
31. Harrison CB, Drummond GR, Sobey CG, Selemidis S (2010) Evidence that
nitric oxide inhibits vascular inflammation and superoxide production via
a p47phox-dependent mechanism in mice. Clin Exp Pharmacol Physiol 37:
429–434.
32. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, et al. (2010) Direct
evidence of a role for Nox2 in superoxide production, reduced nitric oxide
bioavailability, and early atherosclerotic plaque formation in ApoE2/2 mice.
Am J Physiol Heart Circ Physiol 298: H24–32.
33. Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, et al. (2009)
NADPH oxidase isoform selective regulation of endothelial cell proliferation and
survival. Naunyn Schmiedebergs Arch Pharmacol 380: 193–204.
34. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR
(2007) Nitric oxide suppresses NADPH oxidase-dependent superoxide pro-
duction by S-nitrosylation in human endothelial cells. Cardiovasc Res 75: 349–
358.
35. Tannock GA, Paul JA, Barry RD (1984) Relative immunogenicity of the cold-
adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of
A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun
43: 457–462.
Nox1 Oxidase and Influenza A Virus Infection
PLOS ONE | www.plosone.org 12 April 2013 | Volume 8 | Issue 4 | e60792
